- List
- By Topic
- On Map
- Search Details

20672358 [PUBMED-IDS]
Need help? See RSS Feeds
Choose a feed type:

20672358 [PUBMED-IDS] (3 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02458235 | Active, not recruiting | Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation |
|
|
Interventional | Phase 2 |
|
Other |
|
|
67 | All | up to 29 Years (Child, Adult) | NCT02458235 | June 2015 | March 2019 | December 2019 | June 1, 2015 | December 21, 2017 |
|
|||
2 | NCT01617226 | Active, not recruiting | Randomised Study of Azacitidine Versus Azacitidine With Vorinostat in Patients With AML or High Risk MDS |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
260 | All | 18 Years and older (Adult, Senior) | NCT01617226 | RG_11-187 | RAvVA | September 2012 | September 2015 | September 2017 | June 12, 2012 | June 1, 2016 |
|
|
3 | NCT01277484 | Unknown † | Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML |
|
|
Interventional | Phase 1 |
|
Other / Industry |
|
|
19 | All | 18 Years to 65 Years (Adult) | NCT01277484 | DEC-KOR-9007 | PODAC | January 2011 | September 2014 | December 2015 | January 17, 2011 | November 20, 2015 |
|
† Study has passed its completion date and status has not been verified in more than two years.